Evidence gap analysis
Strategic analysis of the sufficiency of evidence to obtain reimbursement and HTA approval in Europe and recommendations about evidence generation
Recent news and posts
Specialized clinical commissioning policies work plan updated in England
On September 11, 2024, NHS England published an updated work plan for specialized clinical commissioning policies development (as of September 02, 2024). One MedTech-related policy was added to the program:
- Long-term left ventricular assist device (LVAD) for destination therapy in adults with heart failure.
The development of the policy “LVAD therapy for advanced heart failure (all ages)” was previously considered in the work plan; however, in July 2023, the development was paused as new evidence that would affect the policy proposition was expected. In the work plan updated in June 2024, the policy was not listed.
No new policies were published from the time of the previous update. The status of ongoing policies was updated.
See the full details here.
This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.